4 |
APIXABAN - FDA APPROVAL 2011
|
18 900 |
8
|
2014-03-16
|
4 |
is apixaban approval by FDA
|
1 140 000 |
5
|
2014-03-23
|
5 |
review proposal to diabetes care
|
448 000 |
0
|
2014-05-19
|
5 |
when will apixaban be fda approved
|
1 010 000 |
-1
|
2015-05-27
|
6 |
NDA. New Drug Application
|
954 000 |
22
|
2014-01-11
|
8 |
orencia
|
391 000 |
0
|
2013-10-16
|
8 |
bristol saxagliptin
|
712 000 |
0
|
2014-08-04
|
9 |
dasatinib verses gleevec
|
33 200 |
4
|
2015-11-03
|
9 |
charles program nda edit response
|
13 400 000 |
0
|
2014-05-12
|
10 |
pdufa delay categories
|
31 400 |
0
|
2014-01-10
|
11 |
abatacept
|
157 000 |
0
|
2014-10-09
|
11 |
how to convert cva to wmv
|
6 820 000 |
0
|
2014-07-01
|
14 |
astrazeneca saxagliptin
|
20 500 |
0
|
2014-06-10
|
14 |
academic patient database
|
27 600 000 |
0
|
2015-11-08
|
15 |
bms critical care contact info
|
247 000 |
0
|
2014-11-18
|
16 |
wmp.pfizer.com
|
2 040 000 |
0
|
2013-11-17
|
16 |
supplemental new drug application
|
2 410 000 |
-5
|
2014-10-07
|
16 |
new lawrenceville
|
24 100 000 |
0
|
2014-10-26
|
17 |
pfizer japan
|
3 560 000 |
0
|
2014-01-08
|
17 |
pes 12 analysis
|
8 670 000 |
0
|
2014-05-21
|
18 |
syngene
|
73 000 |
-6
|
2015-05-22
|
20 |
astra zeneca mexico
|
359 000 |
0
|
2014-01-22
|
20 |
indian bristol
|
10 100 000 |
0
|
2014-06-27
|
20 |
advanced time stop trials
|
15 600 000 |
0
|
2014-09-30
|
21 |
padcoalition.org
|
5 290 |
0
|
2015-02-03
|
21 |
psp stem cell therapy
|
75 700 |
0
|
2014-12-06
|
21 |
Phase III
|
38 500 000 |
0
|
2014-10-10
|
21 |
Consistent Results
|
60 200 000 |
0
|
2014-01-11
|
21 |
accelerated c
|
60 300 000 |
0
|
2015-04-17
|
22 |
hep c interferon
|
257 000 |
0
|
2014-08-31
|
22 |
astrazeneca.com
|
9 690 000 |
0
|
2015-07-11
|
22 |
Press Release Circulation
|
10 200 000 |
0
|
2014-08-19
|
23 |
enfamil dha
|
73 100 |
5
|
2015-03-07
|
23 |
deep stroke 1.7 download
|
15 500 000 |
0
|
2014-10-11
|